RESUMO
In the Central Laboratory of Public Health in Buenos Aires, rabies was detected in a cat that was brought in for diagnosis by its owners. The animal, which was displaying symptoms of the furious form of the disease, had attacked three people in the rural area of Chascomús, near the Rio de la Plata. All three of the people who had been bitten received the necessary treatment. The diagnosis was made using the fluorescent antibody test and the inoculation of mice and the results were communicated to the Zoonoses Division of the Ministry of Health. The virus was then typed at the Institute Pasteur of Buenos Aires using monoclonal antibodies, where it was found to be antigenic variant 4 of serotype 1, i.e., the type of virus usually found in insectivorous bats. This area has been free of the canine variant since 1984. This is the first known case in the province of Buenos Aires of a cat becoming infected with this type of virus. It confirms that there is a link between the air and terrestrial cycles of rabies in this area.
Assuntos
Doenças do Gato/virologia , Vírus da Raiva/classificação , Raiva/veterinária , Animais , Anticorpos Monoclonais , Anticorpos Antivirais/análise , Argentina , Bioensaio/veterinária , Gatos , Quirópteros , Técnica Direta de Fluorescência para Anticorpo/veterinária , Camundongos , Raiva/virologia , Vírus da Raiva/imunologia , Vírus da Raiva/isolamento & purificação , População Rural , Sorotipagem/veterináriaRESUMO
The present work describes the discovery of an organoleptic alteration in some batchs of suckling mouse brain rabies vaccine for human use, produced in the Central Laboratory of Public Health of the Province of Buenos Aires. This alteration consists in the appearance of fibrous particles, light-white, slightly perceptible, suspended in the diluent. The production procedure is that of Fuenzalida and Palacios (4), with the modifications proposed by the Panamerican Zoonoses Center (Larghi and col.) (6), which include a refrigerated centrifugation of the viral suspension to 17,000 g during 10 minutes. This alteration caused 20% or more of dosis loss and a decrease in vaccine potency (2). In order to determine the origin of this alteration, we controlled the homogenization systems, the elements employed, the production of experimental batchs with diversity of isotonizators (dextrose-sucrose) and preservatives, the utilization of glass filters in the treatment of water, all drugs employed, variation of pH of diluent solutions, double centrifugation, the glass employed (ampoules, flasks), pumps of dispensation and wash systems (3) (5). We conclude that the alterations are produced by partial freezing of the infected brain suspension to 10% in water, during the last part of the centrifugation. Particles are formed by irreversible precipitation of a proteic nature (1) (7). It is recommended that during the production of this vaccine the temperature be maintained between 3 to 5 degrees C carefully avoiding freezing the brain suspension in distilled water.
Assuntos
Contaminação de Medicamentos , Vacina Antirrábica , Animais , Centrifugação , Contaminação de Medicamentos/prevenção & controle , Embalagem de Medicamentos , Congelamento , Humanos , Camundongos , TemperaturaRESUMO
The present work describes the discovery of an organoleptic alteration in some batchs of suckling mouse brain rabies vaccine for human use, produced in the Central Laboratory of Public Health of the Province of Buenos Aires. This alteration consists in the appearance of fibrous particles, light-white, slightly perceptible, suspended in the diluent. The production procedure is that of Fuenzalida and Palacios (4), with the modifications proposed by the Panamerican Zoonoses Center (Larghi and col.) (6), which include a refrigerated centrifugation of the viral suspension to 17,000 g during 10 minutes. This alteration caused 20
or more of dosis loss and a decrease in vaccine potency (2). In order to determine the origin of this alteration, we controlled the homogenization systems, the elements employed, the production of experimental batchs with diversity of isotonizators (dextrose-sucrose) and preservatives, the utilization of glass filters in the treatment of water, all drugs employed, variation of pH of diluent solutions, double centrifugation, the glass employed (ampoules, flasks), pumps of dispensation and wash systems (3) (5). We conclude that the alterations are produced by partial freezing of the infected brain suspension to 10
in water, during the last part of the centrifugation. Particles are formed by irreversible precipitation of a proteic nature (1) (7). It is recommended that during the production of this vaccine the temperature be maintained between 3 to 5 degrees C carefully avoiding freezing the brain suspension in distilled water.